These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16175138

  • 1. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Titier K, Picard S, Ducint D, Teilhet E, Moore N, Berthaud P, Mahon FX, Molimard M.
    Ther Drug Monit; 2005 Oct; 27(5):634-40. PubMed ID: 16175138
    [Abstract] [Full Text] [Related]

  • 2. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
    Moreno JM, Wojnicz A, Steegman JL, Cano-Abad MF, Ruiz-Nuño A.
    Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
    [Abstract] [Full Text] [Related]

  • 3. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry.
    Zhang M, Moore GA, Fernyhough LJ, Barclay ML, Begg EJ.
    Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010
    [Abstract] [Full Text] [Related]

  • 4. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
    Parise RA, Ramanathan RK, Hayes MJ, Egorin MJ.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul 05; 791(1-2):39-44. PubMed ID: 12798163
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A, Zanolari B, Rochat B, Montemurro M, Zaman K, Duchosal MA, Ris HB, Leyvraz S, Widmer N, Decosterd LA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul 15; 877(22):1982-96. PubMed ID: 19505856
    [Abstract] [Full Text] [Related]

  • 6. Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays.
    Rezende VM, Rivellis A, Novaes MM, de Alencar Fisher Chamone D, Bendit I.
    Drug Des Devel Ther; 2013 Jul 15; 7():699-710. PubMed ID: 23946646
    [Abstract] [Full Text] [Related]

  • 7. Quantification of the anticancer agent STI-571 in erythrocytes and plasma by measurement of sediment technology and liquid chromatography-tandem mass spectrometry.
    Guetens G, De Boeck G, Highley M, Dumez H, Van Oosterom AT, de Bruijn EA.
    J Chromatogr A; 2003 Dec 05; 1020(1):27-34. PubMed ID: 14661754
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous quantification of erlotinib, gefitinib, and imatinib in human plasma by liquid chromatography tandem mass spectrometry.
    Chahbouni A, den Burger JC, Vos RM, Sinjewel A, Wilhelm AJ.
    Ther Drug Monit; 2009 Dec 05; 31(6):683-7. PubMed ID: 19865001
    [Abstract] [Full Text] [Related]

  • 9. New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
    De Francia S, D'Avolio A, De Martino F, Pirro E, Baietto L, Siccardi M, Simiele M, Racca S, Saglio G, Di Carlo F, Di Perri G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun 15; 877(18-19):1721-6. PubMed ID: 19428316
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
    Kralj E, Trontelj J, Pajič T, Kristl A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug 15; 903():150-6. PubMed ID: 22857863
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
    Miura M, Takahashi N, Sawada K.
    J Chromatogr Sci; 2011 May 15; 49(5):412-5. PubMed ID: 21549035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry.
    Jourdil JF, Tonini J, Stanke-Labesque F.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar 01; 919-920():1-9. PubMed ID: 23384531
    [Abstract] [Full Text] [Related]

  • 15. Analysis of imatinib in bone marrow and plasma samples of chronic myeloid leukaemia patients using solid phase extraction LC-ESI-MS.
    Iqbal Z, Elliott M, Watson DG, Holyoake T, Jørgensen H.
    Pak J Pharm Sci; 2011 Jul 01; 24(3):285-91. PubMed ID: 21715261
    [Abstract] [Full Text] [Related]

  • 16. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
    Zhang Y, Qiang S, Yu Z, Zhang W, Xu Z, Yang L, Wen A, Hang T.
    J Chromatogr Sci; 2014 Apr 01; 52(4):344-50. PubMed ID: 23574742
    [Abstract] [Full Text] [Related]

  • 17. Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.
    Guetens G, Prenen H, De Boeck G, Highley M, de Wever I, van Oosterom AT, de Bruijn EA.
    J Sep Sci; 2006 Feb 01; 29(3):453-9. PubMed ID: 16544888
    [Abstract] [Full Text] [Related]

  • 18. Development and validation of a sensitive assay for the quantification of imatinib using LC/LC-MS/MS in human whole blood and cell culture.
    Klawitter J, Zhang YL, Klawitter J, Anderson N, Serkova NJ, Christians U.
    Biomed Chromatogr; 2009 Dec 01; 23(12):1251-8. PubMed ID: 19517424
    [Abstract] [Full Text] [Related]

  • 19. Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.
    Widmer N, Béguin A, Rochat B, Buclin T, Kovacsovics T, Duchosal MA, Leyvraz S, Rosselet A, Biollaz J, Decosterd LA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr 25; 803(2):285-92. PubMed ID: 15063337
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of imatinib targeted delivery in human leukocytes.
    Kralj E, Žakelj S, Trontelj J, Pajič T, Preložnik Zupan I, Černelč P, Ostanek B, Marc J, Kristl A.
    Eur J Pharm Sci; 2013 Sep 27; 50(1):123-9. PubMed ID: 23643738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.